Summary: Dotmatics has acquired EasyPanel, enhancing its flow cytometry solutions and expanding its scientific software portfolio to offer a comprehensive scientific intelligence platform for multimodal R&D.
Takeaways:
- Enhanced Flow Cytometry Capabilities: The acquisition of EasyPanel, known for its intelligent and automated flow cytometry panel design software, complements Dotmatics’ existing solutions such as OMIQ and FCS Express, facilitating improved experimental outcomes.
- Increased Automation and Data Quality: EasyPanel’s technology supports R&D scientists in generating high-quality data from the outset, enabling better downstream automation and analysis of complex flow cytometry data using advanced machine learning and AI tools.
- Strategic Expansion: EasyPanel is Dotmatics’ 14th acquisition, demonstrating the company’s commitment to providing scientific software and expanding its offerings to deliver end-to-end solutions in flow cytometry and beyond.
Dotmatics, a provider in R&D scientific software connecting science, data, and decision-making, announced the successful acquisition of EasyPanel, a company specializing in flow cytometry panel design software.
The acquisition marks another milestone for Dotmatics, expanding the breadth and depth of its flow cytometry solutions, the company says. EasyPanel is the 14th acquisition by Dotmatics in its work to provide scientists with best-in-class scientific software and a comprehensive scientific intelligence platform for multimodal scientific research & development.
EasyPanel Flow Cytometry Solutions
EasyPanel offers a flow cytometry product that is highly complementary to Dotmatics’ existing capabilities with OMIQ and FCS Express, the company says. Its intelligent and automated flow cytometry panel designer utilizes a proprietary algorithm to suggest optimized panels based on a customer’s test environment for improved experimental impact. Users can also manually edit the suggested panels, receive smart recommendations for gating strategies, and automatically manage their antibody inventory.
“Our flow cytometry customers are working with increasingly sophisticated panels for high dimensional assays, which in turn are generating large amounts of complex data for subsequent analysis,” says Brett Ammundsen, president of Bioinformatics at Dotmatics. “EasyPanel’s panel design permits R&D scientists to generate high quality data at the outset, enabling the full potential of that data to be realized in experimental outcomes when analyzed in software such as OMIQ and FCS Express. Higher quality data also supports increased downstream automation in the analysis of flow cytometry panels. The acquisition of EasyPanel supports our commitment to deliver reliable machine learning and AI tools for advanced automation of flow cytometry analysis, comprising innovations that we’re building into OMIQ, FCS Express, and Dotmatics Luma.”
Flow Cytometry Panel Design
Flow cytometry panel design refers to the process of selecting and combining specific fluorophores and antibodies to analyze multiple parameters (such as cell surface markers, intracellular proteins, and viability indicators) simultaneously on individual cells within a biological sample.
It is the initial step in the flow cytometry phenotyping process, occurring before panel preparation in the wet lab, data acquisition on a flow cytometer, and subsequent analysis using software like FCS Express and OMIQ.
EasyPanel gives Dotmatics a more comprehensive approach to flow cytometry by adding panel design capabilities which will greatly enhance its current offerings, enabling Dotmatics to provide even more robust solutions to its customers.
“This is a big opportunity for EasyPanel to grow and scale our business and help create end-to-end flow solutions together with Dotmatics,” says Omar Abouzid, co-founder and President of EasyPanel. “Our customers and partners can expect the same level of support from EasyPanel as they have received in the past, but now with the benefit of having additional resources and involvement from the Dotmatics flow cytometry team.”
